Free Trial

Vicarious Surgical Q3 2023 Earnings Report

Vicarious Surgical logo
$12.00 -0.03 (-0.25%)
(As of 12/20/2024 04:33 PM ET)

Vicarious Surgical EPS Results

Actual EPS
-$3.60
Consensus EPS
-$4.50
Beat/Miss
Beat by +$0.90
One Year Ago EPS
N/A

Vicarious Surgical Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Vicarious Surgical Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Conference Call Audio

Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)

This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.

Click here for the ticker >>>

Vicarious Surgical Earnings Headlines

BTIG Sticks to Its Hold Rating for Vicarious Surgical (RBOT)
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment
This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.
Vicarious Surgical CFO to Step Down
See More Vicarious Surgical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Vicarious Surgical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vicarious Surgical and other key companies, straight to your email.

About Vicarious Surgical

Vicarious Surgical (NYSE:RBOT). operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

View Vicarious Surgical Profile

More Earnings Resources from MarketBeat

Upcoming Earnings